Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Radioiodine therapy for thyroid cancer

D C Sweeney1, G S Johnston

  • 1Department of Nuclear Medicine, Washington Hospital Center, Washington, DC, USA.

Endocrinology and Metabolism Clinics of North America
|December 1, 1995
PubMed
Summary

Aggressive management, including radioiodine therapy and meticulous follow-up, is crucial for differentiated thyroid cancer patients. Early identification of high-risk individuals is needed to refine treatment strategies for better outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Left-ventricular peak ejection rate, filling rate, and ejection fraction--frame rate requirements at rest and exercise: concise communication.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2013
Same author

Checking applicant backgrounds.

Balance (Alexandria, Va.)·1998
Same author

Solitary cerebellar metastasis from papillary thyroid carcinoma: a case report.

Thyroid : official journal of the American Thyroid Association·1998
Same author

Pharmacokinetics of dacarbazine in the regional perfusion of extremities with melanoma.

Journal of surgical oncology·1996
Same author

Osseous and central nervous system sarcoidosis: scintigraphic and radiographic findings.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·1995
Same author

Benign bone lesions simulating metastases on Tc-99m diphosphonate imaging.

Clinical nuclear medicine·1992

Area of Science:

  • Oncology
  • Nuclear Medicine

Background:

  • Differentiated thyroid cancer (DTC) poses a mortality risk for a subset of patients.
  • Current therapeutic approaches often involve uniform, aggressive treatment for most patients.

Purpose of the Study:

  • To outline an aggressive management strategy for differentiated thyroid cancer.
  • To emphasize the importance of meticulous follow-up and diagnostic procedures.

Main Methods:

  • Aggressive surgery and radioactive iodine (I-131) therapy.
  • Regular monitoring of thyroglobulin levels.
  • Utilizing I-131 diagnostic scans (5-10 mCi) with proper preparation and quality control.
  • Employing additional imaging like thallium scans and MR imaging as necessary.

Main Results:

  • Aggressive management and radioiodine therapy are recommended for differentiated thyroid cancer.
  • Meticulous follow-up with I-131 scans and thyroglobulin monitoring is essential.
  • Current methods lack precise high-risk patient identification.

Conclusions:

  • Aggressive management, including radioiodine therapy, remains the optimal approach for differentiated thyroid cancer.
  • Continued vigilance and comprehensive follow-up are vital due to the lack of definitive high-risk screening tests.
  • Future research should focus on identifying specific markers for aggressive or recurrent thyroid cancer.

Related Experiment Videos